You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

kn046

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Locally Advanced Resectable Gastric Cancer
  • (no location specified)
Sep 3, 2023

Colorectal Cancer Trial (KN046, regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Aug 2, 2023

Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

Recruiting
  • Digestive System Cancers
  • KN046
  • +2 more
  • Beijing, China
    Peking University Cancer Hospital
Oct 25, 2023

HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Colorectal Cancer
  • HER2-positive Biliary Tract Cancer
  • Beijing, State*, China
    Peking University cancer hospital & institution
Aug 2, 2023

Pancreatic Cancer Trial in Shanghai (IN10018, Albumin-Bound Paclitaxel, Gemcitabine)

Recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Renji Hospital of Shanghai Jiaotong University School of Medicin
Apr 23, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Thymic Carcinoma Trial in New York (KN046)

Recruiting
  • Thymic Carcinoma
  • KN046
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

HCC Trial in Beijing (KN046, Lenvatinib)

Recruiting
  • HCC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 12, 2022

Thymic Carcinoma Trial in Shanghai (KN046)

Recruiting
  • Thymic Carcinoma
  • KN046
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
May 16, 2022

Advanced Pancreatic Ductal Adenocarcinoma Trial in Shanghai (KN046, )

Recruiting
  • Advanced Pancreatic Ductal Adenocarcinoma
  • KN046
  • placebo
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Feb 22, 2022

Advanced NSCLC Trial in Shanghai (KN046, Lenvatinib, Docetaxel)

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • KN046
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Mar 7, 2022

Squamous Non-small-cell Lung Cancer Trial in Shanghai (KN046, KN046 )

Active, not recruiting
  • Squamous Non-small-cell Lung Cancer
  • KN046
  • KN046 placebo
  • Shanghai, China
    Shanghai Pulmonary Hospital
Nov 16, 2021

Triple-negative Breast Cancer Trial in Beijing (KN046, Nab-paclitaxel)

Active, not recruiting
  • Triple-negative Breast Cancer
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Nov 16, 2021

Advanced Solid Tumors, Lymphoma Trial in Guangzhou (KN046)

Recruiting
  • Advanced Solid Tumors
  • Lymphoma
  • KN046
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 9, 2020

Stage IV NSCLC Trial in Shanghai (KN046)

Unknown status
  • Stage IV Non-small Cell Lung Cancer
  • KN046
  • Shanghai, China
    Shanghai Pulmonary Hospital
Jul 7, 2020

NSCLC Trial in Guangzhou (KN046, Paclitaxel, Pemetrexed)

Unknown status
  • Non-small Cell Lung Cancer
  • KN046
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 9, 2019

Esophageal Squamous Cell Carcinoma Trial in Suzhou (KN046, palliative radiotherapy)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • KN046
  • palliative radiotherapy
  • Suzhou, China
    The First Affiliated Hospital of Suzhou University
May 27, 2019

Advanced Solid Tumors Trial in Southport (KN046)

Unknown status
  • Advanced Solid Tumors
  • KN046
  • Southport, Queensland, Australia
    ICON Cancer Care
May 20, 2018